EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSNGAG00000022340
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSNGAG00000009866
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSNGAG00000014687
Gene Symbol: AURKC
3 Cross references
96 Possible Orthologues:

Bcl-2-Related Protein A1-Like

Ensembl ID : ENSNGAG00000002014
Gene Symbol: LOC103729441
2 Cross references
113 Possible Orthologues:

Beta-3 Adrenergic Receptor-Like

Ensembl ID : ENSNGAG00000017943
Gene Symbol: LOC103734447
3 Cross references
215 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSNGAG00000019368
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNGAG00000022647
Gene Symbol: BDKRB2
3 Cross references
356 Possible Orthologues:

Bradykinin Receptor, Beta 1

Ensembl ID : ENSNGAG00000022164
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSNGAG00000014253
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSNGAG00000013453
Gene Symbol: CALCRL
3 Cross references
147 Possible Orthologues:

Calcium Channel, Voltage-Dependent, N Type, Alpha 1b Subunit

Ensembl ID : ENSNGAG00000009331
Gene Symbol: CACNA1B
1 Cross references
283 Possible Orthologues:

Calcium Channel, Voltage-Dependent, P/q Type, Alpha 1a Subunit

Ensembl ID : ENSNGAG00000000916
Gene Symbol: CACNA1A
1 Cross references
284 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).